October 14, 2016/Cancer

Meet the New Chair of Colorectal Surgery at Cleveland Clinic

Introducing Scott R. Steele, MD


After 25 years in the U.S. Army, including two deployments to Iraq and two to Afghanistan, Scott R. Steele, MD, is beginning a new mission as Chair of the Department of Colorectal Surgery at Cleveland Clinic. In this profile, learn more about Dr. Steele and the expertise he will bring to Cleveland Clinic’s Digestive Disease & Surgery Institute.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

At a glance

Specialty interests: Clinical outcomes research, minimally invasive surgery, colorectal cancer

Background in brief: Graduated from United States Military Academy at West Point (1994). Earned medical degree from University of Wisconsin (1998). Completed residency in general surgery at Madigan Army Medical Center (2003) and fellowship in colon and rectal surgery at University of Minnesota Medical Center (2005). On active duty from 1998 to 2015, including four combat deployments as a trauma surgeon, and serving at Madigan Army Medical Center as a colorectal surgeon and Associate Program Director of the General Surgery Residency Program. Most recently was Division Chief of Colorectal Surgery at University Hospitals Cleveland Medical Center, as well as Vice Chairman of Clinical Affairs and Associate Director of Surgical Services for the Digestive Health Institute.

Research interests: Currently working on multiple epidemiological and outcomes-based research studies on all aspects of colorectal disease: cancer, inflammatory bowel disease, pelvic floor disorders, endoscopy and anorectal disease.


In his own words

Why colorectal surgery: “A lot of times, colorectal diseases are the ones people don’t talk about, even with their own families. It’s an honor to be trusted by patients and to provide reassurance that I can take care of them. Establishing those close patient relationships is what attracted me to colorectal surgery.”

About combat duty as a U.S. Army surgeon: “There’s no truer medicine than treating an injured soldier on the battlefield. You see young men and women, who in many cases don’t make a lot of money, who are fighting for their country, fighting for their friends, fighting for something they believe in, on foreign soil. I had the privilege of encountering those who were injured in combat, and had the opportunity to treat them — in some cases save their lives — and get them home to their families. That experience will stick with me for a very long time.”

About his proliferation of current research projects: “One of the highlights of doing research is working with medical students, residents and fellows and getting them excited about asking questions. How can we do things better? Is what we think we know truly correct? Is this the best there is? It’s exciting when we find the answers and then see how our research influences the way patients are treated.”


Plans for Cleveland Clinic’s Department of Colorectal Surgery: “My first priorities are to get to know the staff and determine how we can work together, as a collaborative team, to improve the way colorectal disease is treated. We will continuously seek better ways, through our own experience and high-quality research, to improve patient outcomes.”

Trends in colorectal surgery: “Probably the current trend is on introducing Transanal Total Mesorectal Excision (taTME) for patients with low rectal cancer tumors. This newer approach makes the hardest part of the surgery, down in the pelvis, easier to dissect. taTME likely will help improve patient outcomes and speed recovery.

Related Articles

Women's health physician
April 16, 2024/Cancer
Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Mukherjee at Cleveland Clinic
April 1, 2024/Cancer/Blood Cancers
Many Patients with “Indolent” Systemic Mastocytosis Experience Rapid Decline and Lower Survival

First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients